ANDA 77122, held by Impax Labs Inc. Desmopressin Acetate.
As of Nov 16, 2026, ANDA 77122 (Desmopressin Acetate), held by Impax Labs Inc, was first approved by FDA on Jan 25, 2006, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 25, 2006 | Original application | Approved | None posted |
| Desmopressin Acetate0.1MG · tablet;oral | Desmopressin Acetate | Discontinued |
| Desmopressin Acetate0.2MG · tablet;oral | Desmopressin Acetate | Discontinued |
| Feb 23, 2008 | Supplement 2Labeling | Approved | None posted |
| Jan 25, 2006 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters